Home › NDC Lookup › RxCUI directory › RxCUI 801966

4 ML diazepam 5 MG/ML Rectal Gel — RxCUI 801966

RxNorm drug concept · Semantic clinical drug
RxCUI 801966 Semantic clinical drug · SCD ● Current RxNorm concept 11 FDA products 11 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI801966
Official name4 ML diazepam 5 MG/ML Rectal Gel
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asdiazepam 20 mg per 4 ML Rectal Gel; diazePAM 20 MG in 4 ML Rectal Gel
FDA products mapped11
Package NDCs mapped11
Reported Medicaid activity (SDUD)36,750 prescriptions · 52 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Diazepam Rectal: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • No — this medication is specifically for seizure clusters, which are episodes of repeated seizures that are different from your family member's (or your own) usual seizure pattern....
  • When exactly should I give the diazepam rectal gel — as soon as any seizure starts?
  • Yes, the prescriber may authorize a second dose, but there are rules: it can only be given 4 to 12 hours after the first dose, and only if your prescriber has said to do so in your...
  • Can I give a second dose if the seizures don't stop after the first?
📖 Read our full Diazepam Rectal guide →

🕸️ Concept Web — How 4 ML diazepam 5 MG/ML Rectal Gel Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 4 ML diazepam 5 MG/ML Rectal Gel RxCUI 801966

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Diazepam 3322
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Diastat 216586
  3. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Diazepam Rectal Gel 378003
    • Diazepam Rectal Product 1155864
    • Diazepam Rectal Gel [Diastat] 367174
    • Diastat Rectal Product 1166344
    • Rectal Gel 346170
    • Rectal Product 1151127
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Diazepam 5 MG/ML 315799
    • 4 ML diazepam 5 MG/ML Rectal Gel [Diastat] 801965
    • Diazepam 5 MG/ML [Diastat] 1807532

Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Diazepam 5 MG/ML SCDC · 315799
  • Diazepam Rectal Gel SCDF · 378003
  • Diazepam Rectal Product SCDG · 1155864

Brand-Name Concepts

  • 4 ML diazepam 5 MG/ML Rectal Gel [Diastat] SBD · 801965
  • Diazepam 5 MG/ML [Diastat] SBDC · 1807532
  • Diazepam Rectal Gel [Diastat] SBDF · 367174
  • Diastat Rectal Product SBDG · 1166344
  • Diastat BN · 216586

📦 FDA Products & Package NDCs

11 products · 11 package NDCs
11 package NDCs map to RxCUI 801966 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
43386-0280-02 1 PACKAGE in 1 CARTON (43386-280-02) / 2 SYRINGE in 1 PACKA... Diazepam Lupin Pharmaceuticals,Inc. 2023-10-30
43386-0281-02 1 PACKAGE in 1 CARTON (43386-281-02) / 2 SYRINGE in 1 PACKA... Diazepam Lupin Pharmaceuticals,Inc. 2023-10-30
68475-0802-02 2 SYRINGE, PLASTIC in 1 PACKAGE (68475-802-02) / .5 mL in 1... Diazepam Navinta LLC 2026-02-06
68475-0803-02 2 SYRINGE, PLASTIC in 1 PACKAGE (68475-803-02) / 2 mL in 1... Diazepam Navinta LLC 2026-02-06
68475-0804-02 2 SYRINGE, PLASTIC in 1 PACKAGE (68475-804-02) / 4 mL in 1... Diazepam Navinta LLC 2026-02-06
68682-0650-20 2 SYRINGE, PLASTIC in 1 PACKAGE (68682-650-20) / .5 mL in 1... Diazepam Oceanside Pharmaceuticals 1997-07-29
68682-0652-20 2 SYRINGE, PLASTIC in 1 PACKAGE (68682-652-20) / 2 mL in 1... Diazepam Oceanside Pharmaceuticals 1997-07-29
68682-0655-20 2 SYRINGE, PLASTIC in 1 PACKAGE (68682-655-20) / 4 mL in 1... Diazepam Oceanside Pharmaceuticals 1997-07-29
70710-2078-02 2 SYRINGE, PLASTIC in 1 PACKAGE (70710-2078-2) / .5 mL in 1... Diazepam Zydus Pharmaceuticals USA Inc. 2025-12-15
70710-2079-02 2 SYRINGE, PLASTIC in 1 PACKAGE (70710-2079-2) / 2 mL in 1... Diazepam Zydus Pharmaceuticals USA Inc. 2025-12-15
70710-2080-02 2 SYRINGE, PLASTIC in 1 PACKAGE (70710-2080-2) / 4 mL in 1... Diazepam Zydus Pharmaceuticals USA Inc. 2025-12-15
Observed labelers: Navinta LLC (3) · Oceanside Pharmaceuticals (3) · Zydus Pharmaceuticals USA Inc. (3) · Lupin Pharmaceuticals,Inc. (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.